F/M Emr Life Sciences in ETFLFSCETF
13F holders, Q4 2024 (December 31)2holders
$23.39avg. 13F price*
At the end of Q4 2024, 2 institutions reported holding F/M Emr Life Sciences in ETF (LFSC) in their 13F filings. The largest holders were Emerald Mutual Fund Advisers Trust ($46.7M) and Hunter Associates Investment Management LLC ($590K).
- Company
- F/M Emr Life Sciences in ETF
- Filed as
- RBB FD INC (Q4 2024)
- CUSIP
- 74933W221
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $47.3M |
| Exits | 0 | $0 |
Ownership 2 holders
| Emerald Mutual Fund Advisers Trust | 2.84% | New | 1,997,035 | $46.7M |
| Hunter Associates Investment Management LLC | 0.09% | New | 25,310 | $590K |
"% of holder's portfolio" is LFSC's weight in each manager's 13F, not the share of F/M Emr Life Sciences in ETF the manager owns.